Oncolytics Biotech Inc. | Income Statement
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
131.60
163.50
180.40
162.20
90.80
95.40
Gross Income
131.60
163.50
180.40
162.20
90.80
95.40
SG&A Expense
23,823.60
18,431.30
14,789.20
14,960.30
15,579.90
17,109.80
EBIT
23,955.20
18,594.80
14,969.70
15,122.60
15,670.70
17,272.80
Non Operating Income/Expense
56.50
228.10
1,052.00
172.00
65.30
610.10
Pretax Income
23,527.20
18,612.60
13,719.80
15,130.60
15,475.40
16,489.20
Income Tax
5.40
6.80
3.20
9.40
141.50
548
Consolidated Net Income
23,532.60
18,619.30
13,723.00
15,140.00
15,616.90
17,037.20
Net Income
23,532.60
18,619.30
13,723.00
15,140.00
15,616.90
17,037.20
Net Income After Extraordinaries
23,532.60
18,619.30
13,723.00
15,140.00
15,616.90
17,037.20
Net Income Available to Common
23,532.60
18,619.30
13,723.00
15,140.00
15,616.90
17,037.20
EPS (Basic)
2.66
2.01
1.14
1.24
1.14
1.06
Basic Shares Outstanding
8,792.70
9,249.40
11,854.10
12,619.00
13,936.40
16,016.40
EPS (Diluted)
2.68
2.01
1.16
1.20
1.12
1.06
Diluted Shares Outstanding
8,792.70
9,249.40
11,854.10
12,619.00
13,936.40
16,016.40
EBITDA
23,823.60
18,431.30
14,789.30
14,960.30
15,579.90
17,177.40
Non-Operating Interest Income
371.50
210.40
197.90
163.90
130.10
173.50
About Oncolytics Biotech
View Profile
